Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to examine the feasibility and efficacy of a virtual reality program for ambulatory patients with mild-to-moderate chronic gait deficits after stroke.
Virtual reality (VR) systems enable the learning of simple and complex skills in a controlled virtual environment; i.e., one in which the different components (constraints) of the environment can be displayed, graded, changed and monitored in a quantitative manner.
Small preliminary studies suggest that VR may be used to augment chronic stroke rehabilitation and may enhance cortical reorganization. Our aim is to examine the feasibility and efficacy of a virtual reality program for ambulatory patients with mild-to-moderate chronic gait deficits after stroke. Study design-a single center randomized controlled trial of an experimental group and a usual care group.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| A, | Experimental | Virtual Reality training for an overall of 18 sessions 2/week + usual care. |
|
| B, | No Intervention | Usual care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual reality system (CARENâ„¢ Integrated Reality System; MOTEK BV, Netherlands). | Device | Training 2/w for 9 weeks (total 18 sessions). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Community ambulation using Step Activity Monitor (SAM) | Baseline X2, post training (week 9-10), retention (week 20-24) | |
| Gait analysis (GaitRite system) including dual task | Baseline X2, post training (week 9-10), retention (week 20-24) | |
| Body sway- displacement of center of pressure (CoP) as indicated by the reactive forces from platform. | Baseline X2, post training (week 9-10), retention (week 20-24) | |
| Timed Up and Go | Baseline X2, post training (week 9-10), retention (week 20-24) |
| Measure | Description | Time Frame |
|---|---|---|
| Functional Reach | Baseline X2, post training (week 9-10), retention (week 20-24) | |
| Four Stick Stepping Test (FSST) | Baseline X2, post training (week 9-10), retention (week 20-24) | |
Not provided
Main Inclusion Criteria:
Main exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Tanne, MD | Sheba Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sheba Medical Center, Strok Center | Tel Litwinsky | Ramat Gan | 52621 | Israel |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3DGait Analysis system |
| Baseline X2, post training (week 9-10), retention (week 20-24) |
| 6 minute walk | Baseline X2, post training (week 9-10), retention (week 20-24) |
| Self-induced perturbations and reaction to perturbations on platform | Baseline X2, post training (week 9-10), retention (week 20-24) |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |